000 -LEADER | |
---|---|
fixed length control field | 03282nam a22004695i 4500 |
001 - CONTROL NUMBER | |
control field | 978-981-16-5759-7 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240729133627.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 220527s2022 si | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
ISBN | 9789811657597 |
-- | 978-981-16-5759-7 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MJCL |
Source | bicssc |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED062000 |
Source | bisacsh |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MJCL |
Source | thema |
245 10 - TITLE STATEMENT | |
Title | Cancer Biomarkers in Diagnosis and Therapeutics |
250 ## - EDITION | |
Edition statement | 1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Singapore : |
Name of producer, publisher, distributor, manufacturer | Springer Nature Singapore : |
-- | Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice | 2022. |
300 ## - PHYSICAL DESCRIPTION | |
Physical description | XII, 365 p. 1 illus. |
Other physical details | online resource. |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
505 0# - CONTENTS | |
Contents | Chapter 1. Introduction to cancer biomarkers -- Chapter 2.Technologies for identification and validation of cancer biomarkers -- Chapter 3. BIOMARKERS FOR CANCER DRUG DEVELOPMENT -- Chapter 4. Clinical proteomics: diagnostics and prognostic markers of Cancer -- Chapter 5.Microbiome as cancer biomarkers -- Chapter 6. Predictive biomarkers for anticancer drugs -- Chapter 7. Biomarkers in Cancer Survival and Drug Resistance -- Chapter 8. Biomarkers in tumor recurrence and metastasis -- Chapter 9. Biomarkers for Cancer Immunotherapy -- Chapter 10. Role of Biomarkers in Personalized Medicine -- Chapter 11.Development of Novel Cancer Biomarkers for Diagnosis and Prognosis -- Chapter 12. Nanotechnology for Cancer Biomarkers. |
520 ## - ABSTRACT | |
Abstract | This book illustrates the basics and underlying molecular machinery of cancer cells and biochemical assays that detect the type and stage of cancer through cell signaling biomarkers. It starts with a brief introduction to cancer biomarkers and addresses technologies for identifying and validating cancer biomarkers, biomarkers for cancer drug development, prognostic and diagnostic biomarkers, and microbiome as cancer biomarkers. It reviews predictive biomarkers for anticancer drugs, biomarkers in cancer survival and drug resistance, biomarkers in tumor recurrence and metastasis, the role of the biomarker in immunotherapy and personalized medicine, and the development of a novel cancer biomarker. Finally, this book also underpins the role of nanotechnology in the use and detection of cancer biomarkers for enhanced sensitivity and specificity. Lastly, it discusses the challenges with biomarkers in cancer drug discovery and development. This volume is an indispensable tool for researchers working in the field of cancer and also for clinical oncologists. |
650 #0 - SUBJECT HEADINGS | |
Subject term | Tumor markers. |
650 #0 - SUBJECT HEADINGS | |
Subject term | Cancer. |
650 #0 - SUBJECT HEADINGS | |
Subject term | Cancer |
General subdivision | Treatment. |
650 #0 - SUBJECT HEADINGS | |
Subject term | Nanomedicine. |
650 14 - SUBJECT HEADINGS | |
Subject term | Tumour Biomarkers. |
650 24 - SUBJECT HEADINGS | |
Subject term | Cancer Biology. |
650 24 - SUBJECT HEADINGS | |
Subject term | Cancer Therapy. |
650 24 - SUBJECT HEADINGS | |
Subject term | Cancer Nanotechnology. |
700 1# - ADDED PERSONAL NAME | |
Added personal author | Shehzad, Adeeb. |
Relator term | editor. |
710 2# - ADDED CORPORATE NAME | |
Added corporate author | SpringerLink (Online service) |
856 ## - ONLINE RESOURCE | |
Uniform Resource Identifier | <a href="#gotoholdings">#gotoholdings</a> |
Link text | Access resource |
245 ## - TITLE STATEMENT | |
Medium | [E-Book] |
347 ## - DIGITAL FILE CHARACTERISTICS | |
File type | text file |
Encoding format | |
Source | rda |
912 ## - | |
-- | ZDB-2-SBL |
912 ## - | |
-- | ZDB-2-SXB |
Withdrawn status | Lost status | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Source of acquisition | Total Checkouts | Date last seen | Uniform Resource Identifier | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) | Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) | Online | 02/05/2024 | Springer BiomedLifeSc | 02/05/2024 | https://go.openathens.net/redirector/nhs?url=https://doi.org/10.1007/978-981-16-5759-7 | 02/05/2024 | Electronic book |